Suppliers / Pt Fonko International Pharmaceuticals

Pt Fonko International Pharmaceuticals

Indonesia Updated 9 July 2026

Pt Fonko International Pharmaceuticals is a finished-dose manufacturer based in Indonesia. It appears in 4 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with JFDA (JO) and NPRA (MY). Its GMP standing is certified by BPOM (ID). Customs aggregates show $318K of exports covering 31 molecules to 4 destinations in 2025.

0
active US DMFs
0
valid CEPs
0
registered plants
4
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
JFDA (JO) 2 None
NPRA (MY) 2 None
BPOM (ID) None 8

Scale

Year Revenue Exports Destinations
2025 Not reported $318K 4
2024 Not reported $126K 4

Export figures are customs aggregates. We do not publish the identity of any buyer.

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Comparing suppliers?

Choose your molecules and target markets. Pt Fonko International Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts